CRL
Price
$270.93
Change
+$1.56 (+0.58%)
Updated
Mar 28, 6:59 PM EST
34 days until earnings call
ICLR
Price
$335.95
Change
+$6.45 (+1.96%)
Updated
Mar 28, 6:59 PM EST
27 days until earnings call
Ad is loading...

CRL vs ICLR ᐉ Comparison: Which is Better to Invest?

Header iconCRL vs ICLR Comparison
Open Charts CRL vs ICLRBanner chart's image
Charles River Laboratories International
Price$270.93
Change+$1.56 (+0.58%)
Volume$148.94K
CapitalizationN/A
ICON
Price$335.95
Change+$6.45 (+1.96%)
Volume$208.28K
CapitalizationN/A
View a ticker or compare two or three
CRL vs ICLR Comparison Chart

Loading...

CRLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ICLRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CRL vs. ICLR commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and ICLR is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (CRL: $270.93 vs. ICLR: $335.95)
Brand notoriety: CRL and ICLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 28% vs. ICLR: 39%
Market capitalization -- CRL: $13.83B vs. ICLR: $27.18B
CRL [@Medical Specialties] is valued at $13.83B. ICLR’s [@Medical Specialties] market capitalization is $27.18B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileICLR’s FA Score has 1 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • ICLR’s FA Score: 1 green, 4 red.
According to our system of comparison, ICLR is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 3 TA indicator(s) are bullish while ICLR’s TA Score has 3 bullish TA indicator(s).

  • CRL’s TA Score: 3 bullish, 5 bearish.
  • ICLR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CRL is a better buy in the short-term than ICLR.

Price Growth

CRL (@Medical Specialties) experienced а -0.91% price change this week, while ICLR (@Medical Specialties) price change was -0.39% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.79%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was +4.33%.

Reported Earning Dates

CRL is expected to report earnings on May 01, 2024.

ICLR is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Medical Specialties (+0.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for CRL with price predictions.
OPEN
A.I.dvisor published
a Summary for ICLR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ICLR($27.2B) has a higher market cap than CRL($13.8B). ICLR has higher P/E ratio than CRL: ICLR (44.53) vs CRL (29.22). ICLR YTD gains are higher at: 18.681 vs. CRL (14.607). ICLR has higher annual earnings (EBITDA): 1.52B vs. CRL (1.03B). ICLR has more cash in the bank: 380M vs. CRL (277M). CRL has less debt than ICLR: CRL (3.07B) vs ICLR (3.94B). ICLR has higher revenues than CRL: ICLR (8.12B) vs CRL (4.13B).
CRLICLRCRL / ICLR
Capitalization13.8B27.2B51%
EBITDA1.03B1.52B68%
Gain YTD14.60718.68178%
P/E Ratio29.2244.5366%
Revenue4.13B8.12B51%
Total Cash277M380M73%
Total Debt3.07B3.94B78%
FUNDAMENTALS RATINGS
CRL vs ICLR: Fundamental Ratings
CRL
ICLR
OUTLOOK RATING
1..100
7931
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
5718
SMR RATING
1..100
5982
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
2834
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRL's Valuation (77) in the Miscellaneous Commercial Services industry is in the same range as ICLR (80) in the Pharmaceuticals Other industry. This means that CRL’s stock grew similarly to ICLR’s over the last 12 months.

ICLR's Profit vs Risk Rating (18) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRL (57) in the Miscellaneous Commercial Services industry. This means that ICLR’s stock grew somewhat faster than CRL’s over the last 12 months.

CRL's SMR Rating (59) in the Miscellaneous Commercial Services industry is in the same range as ICLR (82) in the Pharmaceuticals Other industry. This means that CRL’s stock grew similarly to ICLR’s over the last 12 months.

CRL's Price Growth Rating (50) in the Miscellaneous Commercial Services industry is in the same range as ICLR (50) in the Pharmaceuticals Other industry. This means that CRL’s stock grew similarly to ICLR’s over the last 12 months.

CRL's P/E Growth Rating (28) in the Miscellaneous Commercial Services industry is in the same range as ICLR (34) in the Pharmaceuticals Other industry. This means that CRL’s stock grew similarly to ICLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLICLR
RSI
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 8 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 4 days ago
66%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
65%
View a ticker or compare two or three
Ad is loading...
CRLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ICLRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMH36.770.52
+1.43%
American Homes 4 Rent
MLYS12.910.14
+1.10%
Mineralys Therapeutics
FULT15.890.15
+0.95%
Fulton Financial Corp
BZUN2.30-0.01
-0.43%
Baozun
ZVSA0.75-0.03
-3.54%
ZyVersa Therapeutics

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+0.58%
IQV - CRL
74%
Closely correlated
+0.12%
DHR - CRL
57%
Loosely correlated
+0.36%
ICLR - CRL
56%
Loosely correlated
+1.96%
A - CRL
56%
Loosely correlated
-1.30%
TMO - CRL
56%
Loosely correlated
+0.32%
More

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been closely correlated with IQV. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
+1.96%
IQV - ICLR
68%
Closely correlated
+0.12%
QGEN - ICLR
63%
Loosely correlated
+0.56%
RGEN - ICLR
62%
Loosely correlated
-0.42%
CRL - ICLR
56%
Loosely correlated
+0.58%
MEDP - ICLR
50%
Loosely correlated
N/A
More